Genetic determinants of non-insulin-dependent diabetes mellitus: Strategies and recent results

Diabetes and Metabolism

Volumn 23, Issue 1, 1997, Pages 7-17

  Velho, G ^a   Froguel, Ph ^b  

^a SAINT LOUIS HOSPITAL   (France)

^b LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

candidate gene; exclusion mapping; linkage analysis; maturity onset diabetes of the young; molecular genetics; non insulin dependent diabetes mellitus; susceptibility genes

Indexed keywords

DISEASE PREDISPOSITION; GENETIC LINKAGE; HUMAN; MOLECULAR GENETICS; MUTATION; NON INSULIN DEPENDENT DIABETES MELLITUS; REVIEW;

CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 12; CHROMOSOMES, HUMAN, PAIR 20; DIABETES MELLITUS, TYPE 2; GENETIC PREDISPOSITION TO DISEASE; GLUCOKINASE; HUMANS; LINKAGE (GENETICS); PEDIGREE;

EID: 0031049080     PISSN: 03381684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (100)

1. DeFronzo RA. The triumvirate : B-cell, muscle, liver. A collusion responsible for NIDDM. Diabetes, 1988, 37, 667-687.
2. Turner RC, Hattersley AT, Shaw JTE, Levy JC. Type II diabetes : clinical aspects of molecular biological studies. Diabetes, 1995, 44, 1-10.
3. Taylor SI, Accili D, Imai Y. Insulin resistance or insulin deficiency : which is the primary cause of NIDDM ? Diabetes, 1994, 43, 735-740.
4. Hamman RF. Genetic and environmental determinants of non-insulin-dependent diabetes mellitus (NIDDM). Diabetes Metab Rev, 1992, 8, 287-338.
5. Clément K, Vaisse C, Manning BS et al. Genetic variation in the beta(3)-adrenergic receptor and an increased capacity to gain weight in patients with morbid obesity. N Engl J Med, 1995, 333, 352-354.
6. Carmelli D, Cardon LR, Fabsitz R. Clustering of hypertension, diabetes, and obesity in adult male twins : same genes or same environments ? Am J Hum Genet, 1994, 55, 566-573.
7. Froguel P, Velho G, Passa P, Cohen D. Genetic determinants of non-insulin-dependent diabetes mellitus : lessons learned from family studies. Diab Metab, 1993, 19, 1-10.
8. Velho G, Froguel P. MODY genes, MODY and NIDDM. Diab Metab, 1997, 23, (in press).
9. Froguel P, Vaxillaire M, Sun F, et al. The glucokinase locus on chromosome 7p is closely linked to early onset non-insulin-dependent diabetes mellitus. Nature, 1992, 356, 162-164.
10. Bell GI, Xiang KS, Newman MV et al. Gene for non-insulin-dependent diabetes mellitus (maturity onset diabetes of the young subtype) is linked to DNA polymorphism on chromosome 20q. Proc Natl Acad Sci USA, 1991, 88, 1484-1488.
11. Vaxillaire M, Boccio V, Philippi A et al. A gene for maturity onset diabetes of the young (MODY) maps to chromosome 12q. Nature Genetics, 1995, 9, 418-423.
12. Froguel P, Zouali H, Vionnel N et al. Familial hyperglycemia due to mutations in glucokinase : definition of a subtype of diabetes mellitus. N Engl J Med, 1993, 328, 697-702.
13. Lathrop M, Lalouel JM, Julier C, Ott J. Multilocus linkage analysis in humans : detection of linkage and estimation of recombination. Amer J Hum Genet, 1985, 37, 482-498.
14. Risen N. Genetic linkage : interpreting Lod Scores. Science, 1992, 255, 803-804.
15. Orkin SH. Reverse genetics and human disease. Cell, 1986, 47, 845-850.
16. Gyapay G, Morissette J. Vignal A et al. The 1993-1994 Généthon human genetic linkage map. Nature Genet, 1994, 7, 246-339.
17. Botstein D, White RL, Skolnick M, Davis RW. Construction of a genetic linkage map in man using restriction fragment length polymorphisms. Am J Hum Genet, 1980, 32, 314-331.
18. Bellanné-Chantelot C, Lacroix B, Ougen P, et al. Mapping the whole human genome by fingerprinting Yeast Artificial Chromosomes. Cell, 1992, 70, 1059-1068.
19. Gauguier D, Froguel P, Parent V et al. Chromosomal mapping of genetic loci associated with non-insulin-dependent diabetes in the GK rat. Nature Genet, 1996, 12, 38-43.
20. Cook JTE, Page RCL, O'Rahilly S, et al. Availability of Type-II diabetic families for detection of diabetes susceptibility genes. Diabetes, 1993, 42, 1536-1543.
21. McCarthy MI, Froguel P, Hitman GA. The genetics of non-insulin-dependent diabetes mellitus : tools and aims. Diabetologia, 1994, 37, 959-968.
22. Ghosh S, Schork NJ. Genetic analysis of NIDDM : the study of quantitative traits. Diabetes, 1996, 45, 1-14.
23. Baier LJ, Sacchettini JC, Knowler WC et al. An amino acid substitution in the human intestinal fatty acid binding protein is associated with increased fatty acid binding, increased fat oxidation, and insulin resistance. J Clin Invest, 1995, 95, 1281-1287.
24. Bingley PJ, Colman P, Eisenbarth GS, et al. Standardization of IVGTT to predict IDDM. Diabetes Care, 1992, 15, 1313-1316.
25. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique : a method for quantifying insulin secretion and resistance. Am J Physiol, 1979, 237, 214-223.
26. Hovorka R, Jones RH. How to measure insulin secretion. Diabetes Metab Rev, 1994, 10, 91-117.
27. Scheen AJ, Paquot N, Castillo MJ, Lefebvre PJ. How to measure insulin action in vivo. Diabetes Metab Rev, 1994, 10, 151-188.
28. Reynet C, Kahn CR. Rad-a member of the ras family overexpressed in muscle of Type-II diabetic humans. Science, 1993, 262, 1441-1444.
29. Weeks DE, Lange K. The affected pedigree member method of linkage analysis. Am J Hum Genet, 1988, 42, 315-326.
30. Holman P. Asymptomatic properties of affected sib-pair linkage analysis. Am J Hum Genet, 1993, 52, 362-374.
31. Cook JTE, Hattersley AT, Levy JC, et aL Distribution of type 2 diabetes in nuclear families. Diabetes, 1993, 42, 106-112.
32. Cox NJ, Bell GI. Disease associations : chance, artifact, or susceptibility genes ? Diabetes, 1989, 38, 947-950.
33. Spielman RS, McGinnis RE, Ewens WJ. Transmission test for linkage disequilibrium : the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet, 1993, 52, 506-516.
34. Bennett ST, Lucassen AM, Gough SCL, et al. Susceptibility to human type I diabetes at IDDM2 is determined by tandem repeat variation at the insulin gene minisatellite locus. Nature Genetics, 1995, 9, 284-292.
35. Hager J, Hansen L, Vaisse C, et al. A missence mutation in the glucagon receptor gene is associated with NIDDM. Nature Genetics, 1995, 9, 299-304.
36. Nishi M, Bell GI, Steiner DF. Islet amyloid polypeptide (amylinl : no evidence of an abnormal precursor sequence in 25 type 2 (non-insulin-dependent) diabetic patients. Diabetologia, 1990, 33, 628-630.
37. Orita M, Suzuki Y, Sekiya T, Hayashi K. Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics, 1989, 5, 874-879.
38. White MB, Carvalho M, Derse D, O'Brien SJ. Detecting single base substitutions as heteroduplex polymorphisms. Genomics, 1992, 12, 301-306.
39. Velho G, Byrne MM, Clément K et al. Clinical phenotypes, insulin secretion and insulin sensitivity in kindreds with maternally inherited diabetes and deafness due to mitochondrial tRNALeu (UUR) gene mutation. Diabetes, 1996, 45, 478-487.
40. Velho G, Vaxillaire M, Boccio V, Charpentier G, Froguel P. Diabetes complications in NIDDM kindreds linked to the MODY-3 locus on chromosome 12q. Diabetes Care, 1996, 19 (in press).
41. Velho G, Pueyo ME, Vaxillaire M, Clément K, Froguel P, Robert J-J. Assessment of insulin secretion and sensitivity in carriers of the diabetes susceptibility haplotype at the MODY-3 locus [Abstract]. Diabetes, 1996, 45 (suppl. 2), 297.
42. Gidh-Jain M, Takeda J, Xu LZ, et al. Glucokinase mutations associated with non-insulin-dependent (type 2) diabetes mellitus have decreased enzymatic activity : implications for structure/function relationships. Proc Natl Acad Sci USA, 1993, 90, 1932-1936.
43. Efrat S, Leiser M, Wu YJ et al. Rybozyme-inediated attenuation of pancreatic beta-cell glucokinase expression in transgenic mice results in impaired glucose-induced insulin secretion. Proc Natl Acad Sci USA, 1994, 91, 2051-2055.
44. Grupe A, Hultgren B, Ryan A, Ma YH, Bauer M, Stewart TA. Transgenic knockouts reveal a critical requirement for pancreatic beta cell glucokinase in maintaining glucose homeostasis. Cell, 1995, 83, 69-78.
45. Bali D, Svetlanov A, Lee HW, et al. Animal model for maturilyonset diabetes of the young generated by disruption of the mouse glucokinase gene. J Biol Chem, 1995, 270, 21464-21467.
46. Wainwright B, Scambler P, Schmidtke J et al. Localization of cystic fibrosis to human chromosome 7cen-q22. Nature, 1985, 318, 384-386.
47. Reed PW, Davies JL, Copeman JB et al. Chromosome-specific microsatellite sets fluorescence-based semi-automated genome mapping. Nature Genet, 1994, 7, 390-395.
48. Hashimoto L, Habita C, Beressi JP et al. Genetic mapping of a susceptibility locus for insulin-dependent diabetes mellitus on chromosome 11q. Nature, 1994, 371, 161-164.
49. Davies JL, Kawaguchi Y, Bennett ST et al. A genome-wide search for human type 1 diabetes susceptibility genes. Nature, 1994, 371, 130-136.
50. Matschinsky FM. A lesson in metabolic regulation inspired by the glucokinase glucose sensor paradigm. Diabetes, 1996, 45, 223-241.
51. Sturis J, Kurland IJ, Byrne MM et al. Compensation in pancreatic beta-cell function in subjects with glucokinase mutations. Diabetes, 1994, 43, 718-723.
52. Velho G, Froguel P, Clément K et al. Primary pancreatic beta-cell secretory defect caused by mutations in the glucokinase in kindreds of maturity onset diabetes of the young. Lancet, 1992, 340, 444-448.
53. Byrne MM, Sturis J. Clément K, et al. Insulin secretory abnormalities in subjects with hyperglycemia due to glucokinase mutations. J Clin Invest, 1994, 93, 1120-1130.
54. Velho G, Petersen KF, Perseghin G, et al. Impaired hepatic glycogen synthesis in glucokinase-deficient (MODY-2) subjects. J Clin Invest, 1996, 98, 1755-1761.
55. Fajans SS. Bell GI, Bowden DW, Halter JB, Polonsky KS. Maturity-onset diabetes of the young. Life Science, 1994, 55, 413-422.
56. Byrne M, Sturis J, Menzel S, et al. Altered insulin secretory responses to glucose in subjects with mutations in the MODY3 gene on chromosome 12q [Abstract]. Diabetes, 1996, 45 (suppl. 2), 76.
57. van den Ouweland JMW, Lemkes HHPJ, Ruitenbeek W et al. Mutation in mitochondrial tRNALeu(UUR) gene in a large pedigree with maternally transmitted type II diabetes mellitus and deafness. Nature Genet, 1992, 1, 368-371.
58. Gerbitz KD, Van den Ouweland JMW, Maassen JA, Jaksch M. Mitochondrial diabetes mellitus : a review. BBA - Mol Basis Dis, 1995, 1271, 253-260.
59. Kadowaki T, Kadowaki H, Mori Y et al. A subtype of Diabetes-Mellitus associated with a mutation of mitochondrial DNA. N Engl J Med, 1994, 330, 962-968.
60. Goto Y, Horai S, Matsuoka T, et al. Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) : a correlative study of clinical features and mitochondrial DNA mutation. Neurology, 1992, 42, 545-550.
61. van den Ouweland JMW, Lemkes HHPJ, Trembath RC et al. Maternally inherited diabetes and deafness is a distinct subtype of diabetes and associates with a single point mutation in the mitochondrial tRNALeu (UUR) gene. Diabetes, 1994, 43, 746-751.
62. Vionnet N, Passa P, Froguel P. Prevalence of mitochondrial gene mutations in families with diabetes mellitus. Lancet, 1993, 342, 1429-1430.
63. Haneda M, Polonsky KS, Bergenstal RM, et al. Familial hyperin-sulinemia due to a structurally abnormal insulin : definition of an emerging new clinical syndrome. N Engl J Med, 1984, 310, 1288-1294.
64. Olansky L, Welling C, Giddings S et al. A variant insulin promoter in non-insulin-dependent diabetes mellitus. J Clin Invest, 1992, 89, 1596-1602.
65. Taylor SI. Molecular mechanisms of insulin resistance : lessons from patients with mutations in the insulin-receptor gene. Diabetes, 1992, 41, 1473-1490.
66. Flier JS. Syndromes of insulin resistance : from patient to gene and back again. Diabetes, 1992, 41, 1207-1219.
67. Almind K, Bjorbaek C, Vestergaard H, Hansen T, Echwald S, Pedersen O. Aminoacid polymorphisms of insulin receptor substrate-1 in Non-Insulin-Dependent Diabetes-Mellitus. Lancet, 1993, 342, 828-832.
68. Hager J, Zouali H, Velho G, Froguel P. Insulin receptor substrate (IRS-1) gene polymorphisms in French NIDDM families. Lancet, 1993, 342, 1430.
69. Hitman GA, Hawrami K, Mccarthy MI et al. Insulin receptor substrate-1 gene mutations in NIDDM ; implications for the study of polygenic disease. Diabetologia, 1995, 38, 481-486.
70. Ura S, Araki E, Kishikawa H, et al. Molecular scanning of the insulin receptor substrate-1 (IRS-1) gene in Japanese patients with NIDDM : identification of five novel polymorphisms. Diabetologia, 1996, 39, 600-608.
71. Elbein SC, Chiu KC, Hoffman MD, Mayorga RA, Bragg KL, Leppert MF. Linkage analysis of 19 candidate regions for insulin resistance in familial NIDDM. Diabetes, 1995, 44. 1259-1265.
72. Groop LC, Kankuri M, Schalin-Jäntti C et al. Association between polymorphism of the glycogen synthase gene and non-insulin-dependent diabetes mellitus. N Engl J Med, 1993, 328, 10-14.
73. Kuroyama H, Sänke T, Ohagi S, Furuta M, Furuta H, Nanjo K. Simple tandem repeat DNA polymorphism in the human glycogen synthase gene is associated with NIDDM in Japanese subjects. Diabetologia, 1994, 37, 536-539.
74. Zouali H, Velho G, Froguel P. Polymorphism of glycogen-synthase gene and non-insulin-dependent diabetes mellitus. N Engl J Med, 1993, 328, 1568.
75. Elbein SC, Hoffman M, Ridinger D, Otterud B, Leppert M. Description of a second microsatellite marker and linkage analysis of the muscle glycogen synthase locus in familial NIDDM. Diabetes, 1994, 43, 1061-1065.
76. Majer M, Mott DM, Mochizuki H, et al. Association of the glycogen synthase locus on 19q13 with NIDDM in Pima Indians. Diabetologia, 1996, 39, 314-321.
77. Bjorback C, Echwald SM, Hubricht P et al. Genetic variants in promoters and coding regions of the muscle glycogen synthase and the insulin-responsive GLUT4 genes in NIDDM. Diabetes, 1994, 43, 976-983.
78. Doria A, Caldwell JS, Ji LN, et al. Trinucleotide repeats at the rad locus : allele distributions in NIDDM and mapping to a 3-cM region on chromosome 16q. Diabetes, 1995, 44, 243-247.
79. Orho M, Carlsson M, Kanninnen T, Groop LC. Polymorphism at the rad gene is not associated with NIDDM in Finns. Diabetes, 1996, 45, 429-433.
80. Hansen L, Hansen T, Vestergaard H, et al. A widespread amino acid polymorphism at codon 905 of the glycogen-associated regulatory subunit of protein phosphatase-1 is associated with insulin resistance and hypersecretion of insulin. Hum Mol Genet, 1995, 4, 1313-1320.
81. Walston J, Silver K, Bogardus C et al. Time of onset of non-insulin-dependent diabetes mellitus and genetic variation in the beta(3)-adrenergic-receptor gene. N Engl J Med, 1995, 333, 343-347.
82. Widen E, Lehto M, Kanninen T, Walston J, Shuldiner AR, Groop LC. Association of a polymorphism in the beta(3)-adrenergic-receptor gene with features of the insulin resistance syndrome in Finns. N Engl J Med, 1995, 333, 348-351.
83. Yki-Jarvinen H. Role of insulin resistance in the pathogenesis of NIDDM. Diabetologia, 1995, 38, 1378-1388.
84. Polonsky KS, Sturis J, Bell GI. Non-insulin-dependent diabetes mellitus-a genetically programmed failure of the beta cell to compensate for insulin resistance. N Engl J Med, 1996, 334, 777-783.
85. Permutt MA, Chiu KC, Tanizawa Y. Glucokinase and NIDDM : a candidate gene that paid off. Diabetes, 1992, 41, 1367-1372.
86. Zouali H, Vaxillaire M, Lesage S et al. Linkage analysis and molecular scanning of the glucokinase gene in NIDDM families. Diabetes, 1993, 42, 1238-1245.
87. Shelton KD, Franklin AJ, Khoor A, Beechem J, Magnuson MA. Multiple elements in the upstream glucokinase promoter contribute to transcription in insulinoma cells. Mol Cell Biol, 1992, 12, 4578-4589.
88. Stone LM, Kahn SE, Fujimoto WY, Deeb SS, Porte D, Jr. A variant at position -30 of the β-cell glucokinase gene promoler is associated with reduced β-cell function in middle-aged Japanese-American men. Diabetes, 1996, 45, 422-428.
89. Poller W, Breizel RG, Bollen CC, Merklein F, Froguel P, Hager J. Association of a glucagon receptor mutation in German patients with familial NIDDM. (Abstract). Diabetes, 1996, 45 (suppl.2), 231.
90. Gough SCL, Saker PJ, Pritchard LE et al. Mutation of the glucagon receptor gene and diabetes mellitus in the UK : association or founder effect ? Hum Mol Genet, 1995, 4, 1609-1612.
91. Jaksch M, Hofmann S, Gerbitz KD. Glucagon receptor gene mutation in NIDDM. Diabetologia, 1996, 39, 248.
92. Than LM, Stolk RP, Jansen JJ, Grobbee DE, Lemkes HHPJ. Maassen JA. Absence of the Gly(40)-Ser mutation in the glucagon receptor among diabetic patients in the Netherlands. Diabetes Care, 1995, 18, 1400-1401.
93. Fujisawa T, Ikegami H, Yamato E et al. A mutation in the glucagon receptor gene (Gly40Ser) : heterogeneity in the association with diabetes mellitus. Diabetologia, 1995, 38, 983-985.
94. Thomas PM, Cote GJ, Wohllk N et al. Mutations in the sulfonylurea receptor gene in familial persistent hyperinsulinemic hypoglycemia of infancy. Science, 1995, 268, 426-429.
95. Inoue H, Ferrer J, Welling CM, et al. Sequence variants in the sulfonylurea receptor (SUR) gene are associated with non-insulin-dependent diabetes mellitus (NIDDM) in Caucasians. Diabetes, 1996, 45 (in press).
96. Stirling B, Cox NJ, Bell GI, Hanis CL, Spielman RS, Concannon P. Linkage studies in NIDDM with markers near the sulphonylurea receptor gene. Diabetologia, 1995, 38, 1479-1481.
97. Yasuda K, Sakura H, Mori Y et al. No evidence for mutations in a putative subunit of the beta cell ATP-sensitive potassium channel (K-ATP Channel) in Japanese NIDDM patients. Biochem Biophys Res Commun, 1995, 211, 1036-1040.
98. Hani EH, Clément K, Velho G et al. Genetic studies of the sulfonylurea receptor gene locus in NIDDM and in morbib obesity among French Caucasians. Diabetes, 1997, 46 (in press).
99. Hanis CL, Boerwinkle E, Chakraborty R et al. A genome-wide search for human non-insulin dependent (type 2) diabetes genes reveals a major susceptibility locus on chromosome 2. Nature Genet, 1996, 13, 161-166.
100. Mahtani MM, Widén E, Lehto M et al. Mapping of a gene for type 2 diabetes associated with an insulin secretion defect by a genome scan in Finnish families. Nature Genet, 1996, 14, 90-94.